JENNIFER REED: Open Payments
NPI 1659094175 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 36 payments from 14 companies in 2025. Trend: 2023 $1,781 · 2024 $1,335 · 2025 $1,356
Food & beverage: $1,250Education: $106
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 6 | $279 |
| Lilly USA, LLC | 4 | $181 |
| Incyte Corporation | 5 | $145 |
| SOBI, INC | 4 | $136 |
| AstraZeneca Pharmaceuticals LP | 4 | $131 |
| Astellas Pharma US Inc | 4 | $127 |
| Adaptive Biotechnologies Corporation | 1 | $118 |
| ABBVIE INC. | 2 | $66 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $33 |
Products named: JAKAFI, CALQUENCE, Cresemba, clonoSEQ, Vonjo, JAYPIRCA, EPKINLY, OJJAARA.
Industry payments across TX — which companies pay providers there.
